Eduard Koifman

Statistics

Publications

Citations

116

H-Index

Active since

2013

Affiliations

Rambam Health Care Campus(Current)

Technion – Israel Institute of Technology

Rappaport Family Institute for Research in the Medical Sciences

Eduard Koifman is an author at Rambam Health Care Campus specializing in inflammatory bowel disease, crohn disease pharmacotherapy, and thiopurine therapy.

ORCID

Publications per year

2013–2024

Publications

Risk Factors for Serious Adverse Effects of Thiopurines in Patients with Crohn&#8217;s Disease

Yoav Mazor, Eduard Koifman, Hela Elkin et al. · Current Drug Safety · 2013 · 31 citations

Medicine, Genetics, Pharmacology +15

Programmed Nanoparticles for Tailoring the Detection of Inflammatory Bowel Diseases and Irritable Bowel Syndrome Disease via Breathprint

Amir Karban, Morad K. Nakhleh, John C. Cancilla et al. · Advanced Healthcare Materials · 2016 · 30 citations

Engineering, Bioengineering, Biosensors +16

Comparative evaluation of a language model and human specialists in the application of European guidelines for the management of inflammatory bowel diseases and malignancies

Matti Waterman, Yuri Gorelik, Itai Ghersin et al. · Endoscopy · 2024 · 18 citations

Medicine, Clinical Sciences, Internal Medicine +14

Thiopurine Effectiveness in Patients with Crohnʼs Disease

Eduard Koifman, Amir Karban, Yoav Mazor et al. · Inflammatory Bowel Diseases · 2013 · 16 citations · Full text

Life Sciences, Genetics, Pharmacology +17

Rac1 Polymorphisms and Thiopurine Efficacy in Children With Inflammatory Bowel Disease

Raffi Lev‐Tzion, Paul Renbaum, Rachel Beeri et al. · Journal of Pediatric Gastroenterology and Nutrition · 2015 · 11 citations

Life Sciences, Genetics, Pharmacology +13

1–5 of 6